Wai-Leng LeeView profile
Senior Lecturer
Dr. Wai-Leng Lee is a Senior Lecturer at the School of Science, Monash University Malaysia, specializing in cancer biology and extracellular vesicles (EVs). She conducts research on EVs as chemoresistance markers and non-invasive diagnostic tools, particularly for prostate and oral cancers. Her work integrates proteomics, spectroscopy, and AI technologies to advance cancer management. Dr. Lee teaches courses in biology, medical cell biology, and molecular biotechnology. She has secured multiple grants, including projects on EV metabolomics and firefly ecology. Her collaboration led to a silver medal-winning non-invasive urine test for prostate cancer. She actively reviews for journals like Cells and Cancers, and serves on the Monash School of Science Imaging Facility committee. Education: PhD in Molecular and Biological Agricultural Sciences, Academia Sinica, Taiwan (2011) MSc in Biology, Universiti Sains Malaysia (2004) BSc (Hons) in Botany & Biology, Universiti Sains Malaysia (2000) Research Focus: Dr. Lee’s research explores EVs’ roles in cancer progression, drug resistance, and diagnostic applications. Key areas include: EV-based biomarkers for early cancer detection EV protein profiles in chemoresistant cancers (e.g., oral squamous cell carcinoma) KRAS-regulated EV biogenesis in colon cancer FTIR spectroscopy for EV analysis AI-driven diagnostic strategies Recent studies include developing an economic EV capture method and AI-integrated FTIR models for prostate cancer screening. Grants & Projects: Principal Investigator for projects on EV metabolomics in hepatocellular carcinoma (2024–2027) Development of aptamer-based biochips for exosome detection (2023–2025) Volatevs: EV studies in drug resistance (2022–2026) Awards & Recognition: Silver Medal, Invention and Design Competition, ITEX’20 (2020) Teaching & Service: Teaches core courses in biology, medical cell signaling, and biotechnology. Oversees the Confocal Microscope Facility, supporting HDR student training and external collaborations. Collaborations: Works with Monash Australia, University of Malaya oncologists, and industry partners on EV diagnostics and drug resistance mechanisms.








